End-to-End Innovations - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

End-to-End Innovations
Integrated lines, flexible machines, and high-barrier materials enhance packaging options.


Pharmaceutical Technology
Volume 33, Issue 3, pp. 52-58

Materials

Pack Expo International also featured several materials of interest to pharmaceutical packagers. A new family of high-barrier metallized polyethylene terephthalate (PET) films serves as a low-cost, lightweight alternative to foil laminations. A 36-gauge metallized PET can replace a 48-gauge foil lamination, which could be expensive and complex. The metallized film bolsters source-reduction efforts by eliminating the need for a sealant layer. Resistant to delamination and compatible with hard-to-hold products, the thin, multilayer films offer oxygen-transmission rates ranging from < 0.01 to 0.15 cm3/100 in.2/day and water-vapor transmission rates ranging from 0.03 to 0.15 g/100 in.2/day ("LumLife MK" PET film, Toray Plastics America, North Kingstown, RI).

Another potential foil replacement is a clear film that offers a strong barrier to oxygen and moisture. The product combines an polychlorotrifluoroethylene (PCTFE) fluoropolymer layer and a polyvinylidene chloride (PVDC) coating. The four-layer polyvinyl chloride (PVC)–PVDC–PCTFE–PVC structure is designed for the most sensitive pharmaceuticals and nutraceuticals. Because PVC is the contact layer, the film does not require special tooling on form–fill–seal equipment. Also available in an opaque version, the film exhibits excellent lay-flat characteristics ("Pentapharm kpMax" films, Klöckner Pentaplast Group, Gordonsville, VA).

A new solvent-free foil lamination designed especially for pharmaceutical overwrap applications is an extrusion-coated 48-gauge PET–low-density polyethylene–35-gauge foil–metallocene PE structure. Despite a significantly thinner sealant layer than competing materials, the metallocene PE forms stronger weld seals at speeds higher than 100 ft/min. Typical applications include secondary packaging for blow–fill–seal unit-dose containers for inhalation therapy or diagnostic kits. Reverse- or surface-printed white or natural foil structure can be supplied in rollstock form or as premade pouches or die-cut lids ("Triad" foil lamination, Rollprint Packaging Products, Addison, IL).

Hallie Forcinio is Pharmaceutical Technology's Packaging Forum editor, 4708 Morningside Drive, Cleveland, OH 44109, tel. 216.351.5824, fax 216.351.5684,


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
42%
Facility/environment problems
0%
Process development problems
8%
Production equipment downtime
8%
Raw material supply problems
25%
Regulatory restrictions
0%
Business decisions to limit production
17%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here